NCT02315755 Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC Status COMPLETED Phase N/A
NCT02307474 A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer Status WITHDRAWN Phase NA
NCT02306954 Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02293980 A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02264548 A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy Status COMPLETED Phase PHASE1
NCT02232646 A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies Status WITHDRAWN Phase PHASE2
NCT02223052 Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT02208128 Molecular Determinants for Therapy Response on Renal Cell Carcinoma Status UNKNOWN Phase NA
NCT02160600 Dual Energy CT vs Standard Triple Phase CT-A Randomised Control Trial Status COMPLETED Phase NA
NCT02143492 Tumor Collection From Routine Nephrectomy for Subjects With Advanced Stage RCC Status COMPLETED Phase N/A
NCT02138578 Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma Status TERMINATED Phase NA
NCT02133742 A Dose Finding Study To Evaluate Safety, Drug Interaction, Tumor Markers Of Axitinib In Combination With MK-3475 In Adult Patients With Previously Untreated Advanced Renal Cell Cancer Status COMPLETED Phase PHASE1
NCT02131376 Investigating a Novel Modifiable Factor Affecting Renal Function After Partial Nephrectomy: Cortical Renorrhaphy Status TERMINATED Phase NA
NCT02089685 Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29) Status COMPLETED Phase PHASE1/PHASE2
NCT02082210 A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02080650 Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) Status COMPLETED Phase NA
NCT02075658 A Comparative Study Between AirSeal, an Integrated Insufflation System, and Conventional Insufflation Status COMPLETED Phase NA